Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats

Physiology and Behavior

Volumn 65, Issue 3, 1998, Pages 563-568

  Bayorh, M A ^a   Ogbolu, E C ^a   Williams, E ^a   Thierry Palmer, M ^a   Sanford, G ^a   Emmett, N ^a   Harris Hooker, S ^a   Socci, R R ^a   Chu, T C ^a   Chenault, V M ^b  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Blood flow; Blood pressure; Cyclic GMP; Dahl rats; Norepinephrine release

Indexed keywords

ALDOSTERONE; ARGIPRESSIN; CYCLIC GMP; POTASSIUM; SODIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SALT INTAKE; STRAIN DIFFERENCE;

EID: 0032425029     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00194-2     Document Type: Article

References (36)

1. 3 from central nervous system tissues by electrical stimulation in vitro. J. Pharmacol. Exp. Ther. 156:31-38; 1967.
2. 3H]nitrobenzyl-thioinosine binding sites. Clin. Exp. Hypertens. 18:37-49; 1996.
3. Berecek, K. H.; Barron, K. W.; Webb, R. L.; Brody, M. J.: Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 4(Suppl. II):II-131-II-137; 1982.
4. Brody, M. J.; Johnson, A. K.: Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. In: Martini, L.; Ganong, W. F., eds. Frontiers in neuroendocrinology. New York: Raven Press; 1980: 249-292.
5. Campese, V. M.; Romoff, M. S.; Levitan, J.; Saglikes, Y.; Fredier, R.; Massry, S. G.: Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 21:371-378; 1982.
6. Chen, P. Y.; Sanders, P. W.: L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88:1559-1567; 1991.
7. Chenault, V. M.; Morris, M.; Lynch, C. D.; Maultsby, S. J.; Hutchins, P. M.: Hormonal and electrolyte responses to acute isohemic volume expansion in unanesthetized rats. Proc. Soc. Exp. Biol. Med. 202:331-337; 1993.
8. Cohen, R. A.; VanHoutte, P. M.: Endothelium-dependent hyperpolarization: Beyond nitric oxide and cyclic GMP. Circulation 92:3337-3349; 1995.
9. Dahl, L. K.; Knudsen, K. D.; Heine, M.; Leitl, G.: Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: Evidence for a humoral factor. J. Exp. Med. 126:687-699; 1967.
10. Dahl, L. K.; Knudsen, K. D.; Iwai, J.: Humoral transmission of hypertension: Evidence from parabiosis. Circ. Res. 24-25(Suppl. 1):21-33; 1969.
11. Dahl, L. K.; Knudsen, K. D.; Iwai, J.: Genetic influence of the kidney in hypertension-prone patients. Circ. Res. 26-27(Suppl. 2):277-289; 1970.
12. Deng, A. Y.; Rapp, J. P.: Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in Dahl salt-sensitive rats. J. Clin. Invest. 95:2170-2177; 1995.
13. Dundore, R. L.; Clas, D. M.; Wheeler, L. T.; Habeeb, P. G.; Bode, D. C.; Buchholz, R. A.; Silver, P. J.; Pagani, E. D.: Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur. J. Pharmacol. 249:293-297; 1993.
14. Ferrario, C. M.; Tramposch, A.; Kawano, Y.; Brosnihan, K. B.: Sodium balance and the reflex regulation of baroreceptor function. Circulation 75(Suppl. I):I-141-I-148; 1987.
15. Folkow, B.; Ely, D. L.: Editorial review. Dietary sodium effects on cardiovascular and sympathetic neuroeffector function as studied in various rat models. J. Hypertens. 5:383-395; 1987.
16. Greenberg, S. S.; Diecke, F. P. J.; Cantor, E.; Peevy, K.; Tanaka, T. P.: Inhibition of sympathetic neurotransmitter release by modulators of cyclic GMP in canine vascular smooth muscle. Eur. J. Pharmacol. 187:409-423; 1990.
17. Loeb, A. L.; Longnecker, D. E.: Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am. J. Physiol. 262:H1494-H1500; 1992.
18. Lüscher, T. F.; Raij, L.; VanHoutte, P. M.: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl strain rats. Hypertension 9:157-163; 1987.
19. Mark, A. L.: Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension 17(Suppl. I):I-86-I-90; 1991.
20. Matsuguchi, H.; Schmid, P. G.; van Orden, K.; Mark, A. L.: Does vasopressin contribute to salt-induced hypertension in the Dahl strain? Hypertension 3:174-181; 1981.
21. Merkel, L.: Zaprinast: A cGMP-selective phosphodiesterase inhibitor. Cardiovasc. Drug Rev. 11:501-515; 1993.
22. Ogidigben, M.; Chu, T. C.; Potter, D. E.: Ocular actions of moxonidine: A possible role of imidazoline receptors. J. Pharmacol. Exp. Ther. 269:897-904; 1994.
23. Paul, R. V.; Wackym, P. S.; Warnock, D. G.: Decreased cyclic GMP response to ANP in mesanglial cells from salt-sensitive (SS-JR) compared to salt-resistant (SR-JR) rats. Hypertension 22:431; 1993.
24. Ryuzaki, M.; Suzuki, H.; Kumagai, K.; Kumagai, H.; Ichikawa, M.; Matsumura, Y.; Saruta, T.: Role of vasopressin in salt-induced hypertension in baroreceptor-denervated uninephrectomized rabbits. Hypertension 17:1085-1091; 1991.
25. Schmieder, R. E.; Rüddel, H.; Schächinger, H.; Bruns, J.; Schulte, W.: Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behav. Med. 19:5-12; 1993.
26. Sigmon, D. H.; Beierwaltes, W. H.: Nitric oxide influences blood flow distribution in renovascular hypertension. Hypertension 23 (Suppl. I):I-34-I-39; 1994.
27. Simchon, S.; Manger, W. M.; Blumberg, G.; Brensilver, J.; Cortell, S.: Impaired renal vasodilation and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension 27:653-657; 1996.
28. Simchon, S.; Manger, W. M.; Brown, T. W.: Dual hemodynamic mechanisms for salt-induced hypertension in salt-sensitive Dahl rats. Hypertension 17:1063-1071; 1991.
29. Simchon, S.; Manger, W. M.; Carlin, R. D.; Peeters, L. L.; Rodriguez, J. R.; Batista, D.; Brown, T.; Merchant, N. B.; Jan, K. M.; Brinberg, D. E.; Chien, S.: Salt-induced hypertension in Dahl salt-sensitive rats: hemodynamics and renal responses. Hypertension 13:612-621; 1989.
30. Sullivan, J. M.: Salt sensitivity: Definition, conception, methodology and long-term issues. Hypertension 19(Suppl. I):I-61-I-68; 1991.
31. Takeshita, A.; Mark, A. L.: Neurogenic contribution to hindquarters vasconstriction during high sodium intake in Dahl strain of genetically hypertensive rat. Circ. Res. 43(Suppl. I):I-86-I-91; 1978.
32. Takeshita, A.; Mark, A. L.; Brody, M. J.: Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine. Am. J. Physiol. 236:H48-H52; 1979.
33. Tobian, L.: Salt and hypertension: Lessons from animal models that relate to human hypertension. Hypertension 17(Suppl. I):I-52-1-60; 1991.
34. Tobian, L.; Ganguli, M.; Goto, A.; Ikeda, T.; Johnson, M. A.; Iwai, J.: The influence of renal prostaglandins, central nervous system and NaCl on hypertension of Dahl S rats. Clin. Exp. Pharmacol. Physiol. 9:341-353; 1982.
35. Tobian, L.; Lange, J.; Azar, S.; Iwai, J.; Koop, D.; Coffee, K.: Reduction of intrinsic natriuretic capacity in kidneys of Dahl hypertension-prone rats. Clin. Res. 25:512; 1977.
36. Weinberger, M. H.: Salt-sensitivity of blood pressure in humans. Hypertension 27:481-490; 1996.